Expression and clinical significance of multi-drug resistance associated protein and P-glycoprotein in non-small-cell lung cancer
Xiaoming Zhao
Abstract
Xiaoming Zhao
Abstract
Objective To observe the expression of the multi-drug resistance associated protein(MRP) and P-glycoprotein(P-gp) in non-small cell lung cancer(NSCLC) tissues, and the relationship between MRP,P-gp and the prognosis of patients' conditions. Methods The expressions of MRP and P-gp in NSCLC were measured by using the S-P immunohistochemistry. Results Among the 42 cases, the positive rate of MRP in NSCLC was 45.2%,the expression of MRP in adeno-carcinoma was higher than that in squamous carcinoma(P 0.05); the positive rate of P-gp in lung cancer tissue was 40.4%,the expression of P-gp was not related to patients' sex,age,clinical stage, differentiation degree of tumor cells(P 0.05),the expressions of P-gp and MRP had positive correlation in lung cancer (P 0.01). The non-tumor survival rate of three year postoperative of negative patients with MRP and P-gp in lung cancer was longer than that in the positive patients with MRP and P-gp (P 0.05). Conclusion P-gp and MRP can be taken for a referential index to judge the clinical effect of the chemotherapy and evaluate prognosis of patients with lung cancer.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the expression of the multi-drug resistance associated protein(MRP) and P-glycoprotein(P-gp) in non-small cell lung cancer(NSCLC) tissues, and the relationship between MRP,P-gp and the prognosis of patients' conditions. Methods The expressions of MRP and P-gp in NSCLC were measured by using the S-P immunohistochemistry. Results Among the 42 cases, the positive rate of MRP in NSCLC was 45.2%,the expression of MRP in adeno-carcinoma was higher than that in squamous carcinoma(P 0.05); the positive rate of P-gp in lung cancer tissue was 40.4%,the expression of P-gp was not related to patients' sex,age,clinical stage, differentiation degree of tumor cells(P 0.05),the expressions of P-gp and MRP had positive correlation in lung cancer (P 0.01). The non-tumor survival rate of three year postoperative of negative patients with MRP and P-gp in lung cancer was longer than that in the positive patients with MRP and P-gp (P 0.05). Conclusion P-gp and MRP can be taken for a referential index to judge the clinical effect of the chemotherapy and evaluate prognosis of patients with lung cancer.
Key concepts: Medicine, Lung cancer, Immunohistochemistry, P-glycoprotein, Internal medicine, Chemotherapy, Drug resistance, Oncology